Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 130 participants.
Also called NCT06341452
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 130 participants
- Sponsor
- Fresenius Medical Care Deutschland GmbH
- Registry
-
NCT06341452
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Czechia
- Registry status
- Recruiting
Technical summary
Registry record NCT06341452. Randomized; no masking; primary purpose treatment. Start 2025-12-16 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis
- Acronym
- SODIAH
- Condition
- End Stage Renal Disease
- Intervention (Device)
- Hemodialysis or Hemodiafiltration either with sodium zero-diffusive treatment or standard treatment without sodium-control
- Lead sponsor
- Fresenius Medical Care Deutschland GmbH
Record details
- Record id
cardio:ct-nct06341452- Content hash
72c6bb0207beaaa5d48fd677011d053da84cdaf445ca62e10421a6238d37c4c5